NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/22/2025
Back to search
Official data from USPTO
SHARC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
11/23/2025
Classification
Registered
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
08/12/2022
Registration date
02/06/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/06/2024
Last transaction
11/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
33
Owner location
BE
Examiner
BLAZICH,JOAN MICHELE
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a purple circle with a dark purple border containing a white wavy line with short white vertical lines emanating from it; to the right of the circle are five yellow circles of varying sizes. Beneath the circles is the stylized blue wording "SHARC".
Holders and representatives
Holders
Celyad Oncology, Société anonyme
Representatives
Todd A. Denys Porzio, Bromberg & Newman, P.C.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationscompositions containing immune cells for use in adoptive cellular therapyimmune cell culturemanufacture of immune cellsbiological preparations for the treatment of cancer; nucleic acid vectors for use in immune cells being biological preparations for the treatment of cancer
Class 42
Scientific laboratory services and researchscientific laboratory services and research related to immune cells and shrna
Class 44
Medical care and medical analysisservices for the diagnosis and treatment of cancerin the field of and related to the manufacturing and administration of immune cells
Publications
History of USPTO decisions and trademark events.
26 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/02/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/10/2024
FIMP
FINAL DISPOSITION PROCESSED
05/10/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/06/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/06/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
02/06/2024
GPNX
NOTIFICATION PROCESSED BY IB
11/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/21/2023
PUBO
PUBLISHED FOR OPPOSITION
11/21/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/01/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/01/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/17/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/14/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/13/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/13/2023
RFNT
REFUSAL PROCESSED BY IB
08/01/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/10/2023
RFRR
REFUSAL PROCESSED BY MPU
07/10/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/03/2023
CNRT
NON-FINAL ACTION WRITTEN
06/02/2023
DOCK
ASSIGNED TO EXAMINER
06/01/2023
MAFR
APPLICATION FILING RECEIPT MAILED
09/27/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/23/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/22/2022
Continuous trademark protection
Get notified about every new filing that threatens SHARC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.